Financial Performance - Net cash used in operating activities for the nine months ended September 30, 2024, was (254.55)million,comparedto97.75 million for the same period in 2023[9]. - For the three months ended September 30, 2024, the net loss from continuing operations was 38.1million,comparedtoanetincomeof23.7 million for the same period in 2023[53]. - The company reported a net loss from continuing operations of 91,000fortheninemonthsendedSeptember30,2024,comparedtoanetincomeof41.2 million for the same period in 2023[116]. - The total underwriting loss for the operating segments was (48,345)thousandforthethreemonthsendedSeptember30,2024,comparedtoaprofitof20,309 thousand in the same period of 2023[72]. - The company reported a loss before taxes of (55,920)thousandforQ32024,comparedtoanincomebeforetaxesof30,735 thousand in Q3 2023[186]. Cash Flow and Investments - The sale of JRG Re generated 96.41millionincash,whilenetcashprovidedbyinvestingactivitieswas321.37 million, a significant increase from (18.02)millionintheprioryear[9].−Cashandcashequivalentsattheendoftheperiodtotaled388.14 million, up from 339.78millionattheendofSeptember2023[9].−Cashprovidedbyinvestingactivitieswas321.4 million for the nine months ended September 30, 2024, including 96.4millionfromthesaleofJRGRe[150].−Thecompanyrecognizednetrealizedandunrealizedinvestmentgainsof6.4 million for the nine months ended September 30, 2024[136]. - The total fair value of fixed maturity securities available-for-sale amounted to 1,215,244,000asofSeptember30,2024[137].DebtandFinancingActivities−Seniordebtrepaymentsamountedto21.5 million, and dividends on Series A preferred shares were 10.5million,contributingtoanetcashusedinfinancingactivitiesof(38.63) million[9]. - The company had a drawn balance of 185.8millionoutstandingonitsunsecuredrevolvingcreditfacilityasofSeptember30,2024[74].−ThefairvalueofseniordebtasofSeptember30,2024,is205,874,000, down from 233,408,000asofDecember31,2023[83].−Theleverageratiowas24.810.5 million, compared to 7.9millionforthesameperiodin2023,reflectinga335.8 million on common shares for the first nine months of 2024, compared to 5.76millionforthesameperiodin2023[89].−TheSeriesAPreferredSharesissuancetotaled150.0 million, with dividends accruing quarterly at an initial rate of 7%[171]. - The total common shares outstanding increased from 37,641,563 at December 31, 2023, to 37,829,475 at September 30, 2024, due to the vesting of RSUs[172]. Underwriting and Loss Ratios - The combined ratio is a key performance measure, with a ratio of less than 100% indicating an underwriting profit[102]. - Underwriting results showed a loss of 56.8millioninQ32024,withacombinedratioof135.511.8 million and a combined ratio of 93.6% in Q3 2023[115]. - The loss ratio increased to 104.1% in Q3 2024 from 67.2% in Q3 2023, primarily due to higher net adverse reserve development[115]. - The nine-month expense ratio increased from 22.5% in the prior year to 24.6% in the current year, primarily due to higher compensation costs[129]. Strategic Transactions - The company completed the sale of JRG Re on April 16, 2024, marking a strategic shift in operations[21]. - The Company entered into a Stock Purchase Agreement to sell JRG Re for an aggregate purchase price of approximately 291.4million,consistingof152.4 million in cash and a 139.0milliondividendfromcontributedsurplus[31].−TheestimatedlossonthesaleofJRGRewasrevisedto78.3 million for the nine months ended September 30, 2024, with a loss on disposal of 2.7millionincludinga2.1 million gain from the change in estimated loss[31]. - The Company entered into a Combined Loss Portfolio Transfer and Adverse Development Cover Reinsurance Contract with State National Insurance Company, effective January 1, 2024, with a reinsurance premium of $313.2 million[58]. Legal and Regulatory Matters - The Company is involved in various legal proceedings, including a class action lawsuit filed on November 13, 2023, alleging violations of the Securities Exchange Act of 1934, with claims for unspecified damages[63]. - The Company filed a complaint against Fleming Intermediate Holdings LLC for breach of the Stock Purchase Agreement, seeking specific performance and damages[64]. - The Company intends to vigorously defend against claims made by Fleming, which include common law fraud and breaches of contract[64]. Market and Risk Management - The company has identified primary market risks including interest rate risk associated with fixed maturities and equity price risk related to equity securities[192]. - There is no material exposure to foreign currency exchange rate risk or commodity risk[192]. - The company closely monitors its exposure compared to collateral held and requests additional collateral when necessary[67].